Open Clinical Trials:
CLINICAL TRIAL 19722
A Phase 2, Multi-Cohort, Open-Label, Multicenter Study To Determine The Efficacy And Safety Of Bb2121 In Subjects With Relapsed And Refractory Multiple Myeloma And In Subjects With High-Risk Multiple Myeloma Having Progressed Within One Year Of Initial Treatment
Disease Site: Multiple Myeloma
View Trial DetailsCLINICAL TRIAL 20141
A Randomized Study of Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Patients with Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant
Disease Site: Multiple Myeloma
View Trial DetailsCLINICAL TRIAL 20253
Open Label, Multi-Center, Phase 1b Clinical Trial to Evaluate the Safety and Efficacy of Autologous CAR-BCMA T cells (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma
Disease Site: Multiple Myeloma
View Trial DetailsCLINICAL TRIAL 21204
Phase II Multicenter Trial of anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for Multiple Myeloma Patients with Sub-Optimal Response After Autologous Hematopoietic Cell Transplantation and Maintenance Lenalidomide
Disease Site: Multiple Myeloma
View Trial DetailsCLINICAL TRIAL 21249
A Phase 2, Open-Label, Multi-Center Study of Venetoclax in Combination with Carfilzomib and Dexamethasone in Subjects with Relapsed or Refractory Multiple Myeloma
Disease Site: Multiple Myeloma
View Trial DetailsCLINICAL TRIAL 21550
A Phase 1, Multi-center, Open-label, Dose Finding Study of CC-92328 in Subjects with Relapsed and/or Refractory Multiple Myeloma
Disease Site: Multiple Myeloma
View Trial DetailsCLINICAL TRIAL 21551
A Phase 2, Open-Label Randomized Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone vs Carfilzomib, Lenalidomide, and Dexamethasone in Patients with Newly-Diagnosed Multiple Myeloma (ADVANCE)
Disease Site: Multiple Myeloma
View Trial DetailsCLINICAL TRIAL 21858
A Phase 2, Multicohort Study of Daratumumab-Based Therapies in Participants with Amyloid Light Chain AL Amyloidosis
Disease Site: Multiple Myeloma
View Trial DetailsCLINICAL TRIAL 22177
Intermediate-Size Population Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (cilta-cel) Out-of-Specification (OOS) in Patients with Multiple Myeloma
Disease Site: Multiple Myeloma
View Trial DetailsCLINICAL TRIAL 22449
Expanded Access Program for belantamab mafodotin in Patients with Relapsed/Refractory Multiple Myeloma who are Refractory to a Proteasome Inhibitor, and an Immunomodulatory Agent, and an Anti-CD38 Antibody
Disease Site: Multiple Myeloma
View Trial DetailsCLINICAL TRIAL 22115
Feasibility Of Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
Disease Site: Leukemia, other, Multiple Myeloma
View Trial DetailsCLINICAL TRIAL 18926
The National Myelodysplastic Syndromes (MDS) Study
Disease Site: Leukemia, other, Lymphoid Leukemia, Multiple Myeloma, Myeloid and Monocytic Leukemia
View Trial DetailsCLINICAL TRIAL 20156
Mindfulness in AYA Patients Undergoing Hematopoietic Stem Cell Transplantation: A Pilot Proposal
Disease Site: Multiple Myeloma, Unknown Sites, Leukemia, other
View Trial DetailsCLINICAL TRIAL 20816
Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant
Disease Site: Multiple Myeloma
View Trial DetailsCLINICAL TRIAL 21752
Chimeric Antigen Receptor T-Cell Therapy: Neurocognitive Effects and Patient-Reported Outcomes
Disease Site: Hodgkin's Lymphoma, Leukemia, other, Lymphoid Leukemia, Multiple Myeloma, Myeloid and Monocytic Leukemia, Non-Hodgkin's Lymphoma, Other Hematopoietic
View Trial DetailsCLINICAL TRIAL 22083
Real-World Clinical and Patient-Reported Outcomes Among Patients With Relapsed/Refractory Multiple Myeloma treated With Commercial CAR-T Therapy
Disease Site: Multiple Myeloma
View Trial DetailsCLINICAL TRIAL 21219
Predicting Progression of Developing Myeloma in a High-Risk Screened Population
Disease Site: Multiple Myeloma
View Trial Details